Acadian Asset Management LLC Puma Biotechnology, Inc. Transaction History
Acadian Asset Management LLC
- $57.3 Billion
- Q3 2025
A detailed history of Acadian Asset Management LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 2,053,305 shares of PBYI stock, worth $10.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,053,305
Previous 2,008,146
2.25%
Holding current value
$10.2 Million
Previous $6.89 Million
58.32%
% of portfolio
0.02%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding PBYI
# of Institutions
135Shares Held
35.2MCall Options Held
264KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY4.13MShares$20.4 Million11.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.69MShares$18.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$17.7 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.15MShares$10.6 Million0.02% of portfolio
-
American Century Companies Inc Kansas City, MO1.48MShares$7.34 Million0.0% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $226M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...